The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Guest Editorial

From the chairs of ECOG-ACRIN: A perspective on indirect costs

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

Indirect costs are a component of a grant award that recognizes expenses for a project that, for efficiency’s sake, are aggregated across projects and divided proportionally to projects rather than explicitly charged to each project. They are influenced by location and services provided. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Peter J. O'Dwyer, MD
Co-chair, ECOG-ACRIN Cancer Research Group; Professor of medicine, University of Pennsylvania
Mitchell D. Schnall, MD, PhD
Co-chair, ECOG-ACRIN Cancer Research Group; Senior vice president for Data and Technology Solutions, Professor of radiology, University of Pennsylvania
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

Different KRAS mutations affect how tumors interact with the immune system, UTSW-led study finds

KRAS is the most frequently mutated oncogene across all human cancers. Although different KRAS mutations have long been thought to exert the same cancer-driving effects, a new study led by UT Southwestern Medical Center researchers suggests that different KRAS mutation types can variously impact how cancer cells interact with immune cells, significantly affecting the malignant cells’ behavior. 
Byline
Peter J. O'Dwyer, MD
Co-chair, ECOG-ACRIN Cancer Research Group; Professor of medicine, University of Pennsylvania
Mitchell D. Schnall, MD, PhD
Co-chair, ECOG-ACRIN Cancer Research Group; Senior vice president for Data and Technology Solutions, Professor of radiology, University of Pennsylvania
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account